Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
29M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
130K
-
Shares change
-
-141K
-
Total reported value, excl. options
-
$106K
-
Value change
-
-$165K
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$0.81
Significant Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q3 2023
12 filings reported holding ITRM - Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share as of Q3 2023.
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 130K shares
of 29M outstanding shares and own 0.45% of the company stock.
Largest 10 shareholders include SUSQUEHANNA INTERNATIONAL GROUP, LLP (47.7K shares), RENAISSANCE TECHNOLOGIES LLC (46.9K shares), CITADEL ADVISORS LLC (19.6K shares), MORGAN STANLEY (14K shares), WELLS FARGO & COMPANY/MN (1.29K shares), Kelly Financial Services LLC (120 shares), NewEdge Advisors, LLC (100 shares), Tower Research Capital LLC (TRC) (22 shares), HM PAYSON & CO (3 shares), and NATIONAL BANK OF CANADA /FI/ (2 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.